BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9
29 results:

  • 1. Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer.
    Rosova B; Proks J; Filipova A; Hadzi Nikolov D; Chloupkova R; Richter I; Szabo A; Rozsypalova A; Matej R; Melichar B; Buchler T; Dvorak J
    Neoplasma; 2023 Dec; 70(6):796-803. PubMed ID: 38247336
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of Homologous Recombination Deficiency in Ovarian cancer.
    Garg V; Oza AM
    Clin Cancer Res; 2023 Aug; 29(16):2957-2960. PubMed ID: 37347464
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pan-cancer Analysis Identifies
    Ragusa D; Tosi S; Sisu C
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429006
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive network analysis of dysregulated genes revealed mnx1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response.
    Wu A; Liu J; Zhang X; Niu C; Shu G; Yin G
    Cancer Sci; 2022 Aug; 113(8):2627-2641. PubMed ID: 35639251
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. mnx1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages.
    Kato H; Tateishi K; Fujiwara H; Nakatsuka T; Yamamoto K; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Ijichi H; Otsuka M; Iwadate D; Oyama H; Kanai S; Noguchi K; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito K; Saito T; Takahara N; Kishikawa T; Hamada T; Takahashi R; Miyabayashi K; Mizuno S; Kogure H; Nakai Y; Hirata Y; Toyoda A; Ichikawa K; Qu W; Morishita S; Arita J; Tanaka M; Ushiku T; Hasegawa K; Fujishiro M; Koike K
    Gastroenterology; 2022 Apr; 162(4):1272-1287.e16. PubMed ID: 34953915
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA mnx1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
    Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
    Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
    Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension.
    Kose F; Alemdaroglu S; Mertsoylu H; Besen AA; Guler OC; Simsek SY; Erbay G; Onal C; Celik H
    J BUON; 2020; 25(4):1928-1934. PubMed ID: 33099934
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience.
    Thakur JD; Corlin A; Mallari RJ; Huang W; Eisenberg A; Sivakumar W; Krauss H; Griffiths C; Rettinger S; Cohan P; Barkhoudarian G; Araque KA; Kelly D
    Pituitary; 2021 Feb; 24(1):14-26. PubMed ID: 32936381
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
    Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
    J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Application of the optimized and validated LC-MS method for simultaneous quantification of tryptophan metabolites in culture medium from cancer cells.
    Sadok I; Rachwał K; Staniszewska M
    J Pharm Biomed Anal; 2019 Nov; 176():112805. PubMed ID: 31415991
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Application of nuclear magnetic dispersion weighted imaging and apparent diffusion coefficient in the identification of benign].
    Li ZL; Nan J; Cui YT; Du XS; Hao HC; Zhang JF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 33(4):342-346. PubMed ID: 30970406
    [No Abstract]    [Full Text] [Related]  

  • 15. Overexpression of lncRNA mnx1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long Noncoding RNA mnx1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Validation of Revised FIGO Staging Classification for cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic analyses identify molecular subtypes of pancreatic cancer.
    Bailey P; Chang DK; Nones K; Johns AL; Patch AM; Gingras MC; Miller DK; Christ AN; Bruxner TJ; Quinn MC; Nourse C; Murtaugh LC; Harliwong I; Idrisoglu S; Manning S; Nourbakhsh E; Wani S; Fink L; Holmes O; Chin V; Anderson MJ; Kazakoff S; Leonard C; Newell F; Waddell N; Wood S; Xu Q; Wilson PJ; Cloonan N; Kassahn KS; Taylor D; Quek K; Robertson A; Pantano L; Mincarelli L; Sanchez LN; Evers L; Wu J; Pinese M; Cowley MJ; Jones MD; Colvin EK; Nagrial AM; Humphrey ES; Chantrill LA; Mawson A; Humphris J; Chou A; Pajic M; Scarlett CJ; Pinho AV; Giry-Laterriere M; Rooman I; Samra JS; Kench JG; Lovell JA; Merrett ND; Toon CW; Epari K; Nguyen NQ; Barbour A; Zeps N; Moran-Jones K; Jamieson NB; Graham JS; Duthie F; Oien K; Hair J; Grützmann R; Maitra A; Iacobuzio-Donahue CA; Wolfgang CL; Morgan RA; Lawlor RT; Corbo V; Bassi C; Rusev B; Capelli P; Salvia R; Tortora G; Mukhopadhyay D; Petersen GM; ; Munzy DM; Fisher WE; Karim SA; Eshleman JR; Hruban RH; Pilarsky C; Morton JP; Sansom OJ; Scarpa A; Musgrove EA; Bailey UM; Hofmann O; Sutherland RL; Wheeler DA; Gill AJ; Gibbs RA; Pearson JV; Waddell N; Biankin AV; Grimmond SM
    Nature; 2016 Mar; 531(7592):47-52. PubMed ID: 26909576
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ovarian Suspension With Adjustable Sutures: An Easy and Helpful Technique for Facilitating Laparoendoscopic Single-Site Gynecologic Surgery.
    Chen KH; Chen LR; Seow KM
    J Minim Invasive Gynecol; 2015; 22(5):767-75. PubMed ID: 25757814
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Image-guided ovarian mass biopsy: efficacy and safety.
    Thabet A; Somarouthu B; Oliva E; Gervais DA; Hahn PF; Lee SI
    J Vasc Interv Radiol; 2014 Dec; 25(12):1922-1927.e1. PubMed ID: 25241300
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.